Post-Covid disorders of nervous system: personal experience

Cover Page

Cite item

Full Text

Abstract

Introduction. In the COVID-19 pandemic, high lethality as well as long-term outcomes are getting more and more relevant. According to the accumulated study results, COVID-19 affects the nervous system both directly and indirectly.

Objective: to study the variants of post-COVID syndrome based on the data from the State Novosibirsk Regional Clinical Hospital from July 2020 to February 2022.

Materials and methods. We have performed post hoc analysis of the medical records of 1,500 patients with a past history of COVID-19 admitted following various neurological disorders manifested from July 2020 to February 2022.

Results. While temporary and pathogenetic association with past COVID-19 was revealed in 455 patients, primary involvement of the central nervous system was reported in 91.6% of cases, primary involvement of the peripheral nervous system — in 8.1% of cases, and musculoskeletal disorder (idiopathic myodystrophy) — in 0.3% of cases.

Conclusion. Prevalence of the neurological variants of post-COVID syndrome is still unknown. However, patients with severe COVID-19 are more susceptible to neurological complications during the following six months.

About the authors

Larisa A. Shchepankevitch

Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital; Federal Research Center of Fundamental and Translational Medicine

Author for correspondence.
Email: shepankevich@rambler.ru
ORCID iD: 0000-0001-6951-2205

D. Sci. (Med.), Assocoated Professor, Head, Neurology Department, Novosibirsk State Medical University; Curator, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital; Main Researcher, Federal Research Center of Fundamental and Translational Medicine

Russian Federation, Novosibirsk; Novosibirsk; Novosibirsk

Ivan E. Arkhipov

Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital

Email: shepankevich@rambler.ru
ORCID iD: 0000-0003-2740-6388

Neurologist, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital

Russian Federation, Novosibirsk; Novosibirsk

Veronika V. Polyanskaya

Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital

Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-5122-2549

Student, Novosibirsk State Medical University; Assistant of Neurologist, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital

Russian Federation, Novosibirsk; Novosibirsk

Ivan A. Veretelnikov

State Novosibirsk Regional Clinical Hospital

Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-8587-5679

Chief, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital

Russian Federation, Novosibirsk

Elena V. Taneeva

State Novosibirsk Regional Clinical Hospital

Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-6538-6069

Chief, Regional Vascular Center No. 2, State Novosibirsk Regional Clinical Hospital

Russian Federation, Novosibirsk

Ksenya V. Rerikh

Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital

Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-4141-9161

Neurologist, Regional Vascular Center No. 2, State Novosibirsk Regional Clinical Hospital

Russian Federation, Novosibirsk; Novosibirsk

References

  1. Lopez-Leon S., Wegman-Ostrosky T., Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021; 11(1): 16144. doi: 10.1038/s41598-021-95565-8
  2. Mao L., Jin H., Wang M. et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–690. doi: 10.1001/jamaneurol.2020.1127
  3. Román G.C., Gracia F., Torres A. et al. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front. Immunol. 2021; (12): 653786. doi: 10.3389/fimmu.2021.653786
  4. Stefanou M.I., Palaiodimou L., Bakola E. et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther. Adv. Chronic Dis. 2022; 13: 20406223221076890. doi: 10.1177/20406223221076890
  5. Brann D.H., Tsukahara T., Weinreb C. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020; 6(31): eabc5801. doi: 10.1126/sciadv.abc5801
  6. Танашян М.М., Кузнецова П.И., Раскуражев А.А. Неврологические аспекты СOVID-19. Анналы клинической и экспериментальной неврологии. 2020; 14(2): 62–69. Tanashyan M.M., Kuznetsova P.I., Raskurazhev A.A. Neurological aspects of COVID-19. Annals of clinical and experimental neurology 2020; 14(2): 62–69. (In Russ.) doi: 10.25692/ACEN.2020.2.8
  7. Barrantes F.J. Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem. Neurosci. 2020; 11(18): 2793–2803. doi: 10.1021/acschemneuro.0c00434
  8. Palaiodimou L., Stefanou M.I., Katsanos A.H. et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur. J. Neurol. 2021; 28(10): 3517–3529. doi: 10.1111/ene.14860
  9. Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020; 16: 636–644. doi: 10.1038/s41582-020-0398-3
  10. Graham E.L., Clark J.R., Orban Z.S. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”. Ann. Clin. Transl. Neurol. 2021; 8(5): 1073–1085. doi: 10.1002/acn3.51350
  11. Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 2020; 8(6): e46–e47. doi: 10.1016/S2213-2600(20)30216-2
  12. Lechien J.R., Chiesa-Estomba C.M., De Siati D.R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 2020; 277(8): 2251–2261. doi: 10.1007/s00405-020-05965-1
  13. Mainali S., Darsie M.E. Neurologic and neuroscientific evidence in aged COVID-19 patients. Front. Aging Neurosci. 2021; 13: 648662. doi: 10.3389/fnagi.2021.648662
  14. Wang F., Kream R.M., Stefano G.B. Long-term respiratory and neurological sequelae of COVID-19. Med. Sci. Monit. 2020; 26: e928996. doi: 10.12659/MSM.928996
  15. Белопасов В.В., Яшу Я., Самойлова Е.М., Баклаушев В.П. Поражение нервной системы при СOVID-19. Клиническая практика. 2020; 11(2): 60–80. Belopasov V.V., Yachou Ya., Samoilova E.M., Baklaushev V.P. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020; 11(2): 60–80. (In Russ.) doi: 10.17816/clinpract34851
  16. Taquet M., Geddes J.R., Husain M. et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5): 416–427. doi: 10.1016/S2215-0366(21)00084-5

Copyright (c) 2023 Shchepankevitch L.A., Arkhipov I.E., Polyanskaya V.V., Veretelnikov I.A., Taneeva E.V., Rerikh K.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies